Direkt zum Inhalt
Merck
  • miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.

miR-203 suppresses the proliferation and migration and promotes the apoptosis of lung cancer cells by targeting SRC.

PloS one (2014-08-21)
Nan Wang, Hongwei Liang, Yong Zhou, Chen Wang, Suyang Zhang, Yi Pan, Yanbo Wang, Xin Yan, Junfeng Zhang, Chen-Yu Zhang, Ke Zen, Donghai Li, Xi Chen
ZUSAMMENFASSUNG

SRC, also known as proto-oncogene c-Src, is a non-receptor tyrosine kinase that plays an important role in cancer progression by promoting survival, angiogenesis, proliferation, and invasion pathways. In this study, we found that SRC protein levels were consistently upregulated in lung cancer tissues, but that SRC mRNA levels varied randomly, suggesting that a post-transcriptional mechanism was involved in SRC regulation. Because microRNAs (miRNAs) are powerful post-transcriptional regulators of gene expression, we used bioinformatic analyses to search for miRNAs that potentially target SRC. We identified specific targeting sites for miR-203 in the 3'-untranslated region (3'-UTR) of SRC. We then experimentally validated miR-203 as a direct regulator of SRC using cell transfection and luciferase assays and showed that miR-203 inhibited SRC expression and consequently triggered suppression of the SRC/Ras/ERK pathway. Finally, we demonstrated that the repression of SRC by miR-203 suppressed the proliferation and migration and promoted the apoptosis of lung cancer cells. In summary, this study provides the first clues regarding the role of miR-203 as a tumor suppressor in lung cancer cells through the inhibition of SRC translation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ras-Aktivierungsassay-Kit
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Src